The traditional indica/sativa/hybrid categorization is a useful simplification but increasingly viewed by botanists and cannabis researchers as scientifically imprecise. Modern cannabis is better understood by chemotype — cannabinoid + terpene profile — than by indica/sativa labels.
The traditional 'indica vs sativa vs hybrid' categorization remains the most common way cannabis is described at retail — but modern botanical and pharmacological research increasingly views this taxonomy as scientifically imprecise. Most cannabis sold today is a hybrid of historical landrace genetics, and the actual psychoactive and physiological effects of a cultivar are driven by its chemotype — the combined cannabinoid (THC, CBD, CBN, etc.) and terpene profile — rather than by its indica/sativa label. This guide explains the traditional categorization, the limitations of that framework per peer-reviewed cannabis research, and what chemotype-based analysis offers as a more reliable predictor of effect.
Cannabis is traditionally categorized into three groups. Indica strains are typically described as short, broad-leaf, originating in Central Asia (Hindu Kush region), and producing sedating, body-relaxing effects. Sativa strains are typically described as tall, narrow-leaf, originating in equatorial regions (Mexico, Colombia, Thailand), and producing stimulating, cerebral, energetic effects. Hybrid strains blend indica and sativa genetics — the majority of modern cannabis is hybrid.
Peer-reviewed cannabis taxonomy research — including work by Dr. Jonathan Page (University of British Columbia) and colleagues — argues that nearly all modern cannabis cultivars are hybrids of historical landrace genetics, making strict indica/sativa categorization scientifically misleading. The morphological differences (leaf shape, plant structure) that historically defined indica vs sativa do not consistently predict chemical profile or effect.
“The dichotomy between Sativa and Indica is essentially a vernacular term and does not reflect modern cannabis genetics in any meaningful way.”
A cannabis chemotype is the cannabinoid + terpene profile of a specific cultivar. Researchers classify cannabis into chemotypes such as: Type I (THC-dominant), Type II (balanced THC:CBD), Type III (CBD-dominant), with secondary classification by dominant terpene (myrcene-dominant, limonene-dominant, pinene-dominant, etc.). Chemotype is a more reliable predictor of effect than indica/sativa labeling because it describes the actual pharmacologically active compounds — not morphological traits.
Cannabis cannabinoids include THC (psychoactive), CBD (non-intoxicating), CBN (mild sedating, degradation product of THC), CBG (precursor cannabinoid), THCV (varin variant), and others. Modern lab-tested cannabis reports cannabinoid percentages by weight on the certificate of analysis (COA). Adult-use cannabis flower typically ranges 15-30% THC; CBD-dominant cultivars typically report 8-20% CBD with lower THC.
Alongside cannabinoids, terpenes — aromatic hydrocarbon compounds — are the second component of chemotype. The major cannabis terpenes (myrcene, limonene, pinene, linalool, caryophyllene, humulene, terpinolene, ocimene) influence flavor and may modulate effect via the proposed entourage effect. See the Waabigwan Mashkiki terpenes guide for detail on each major terpene's aroma and effect associations.
Despite the scientific imprecision of indica/sativa labels, they remain useful shorthand at retail. For practical buying: indica-leaning cultivars are commonly chosen for evening/sleep; sativa-leaning for daytime/social/creative; hybrid for balance. For more precision, ask the budtender for the chemotype — specifically the dominant terpene and cannabinoid ratio. Waabigwan Mashkiki provides terpene profile cards on cultivar information in-store.